Chandler Robinson

All filings by Chandler Robinson on record concern Monopar Therapeutics, in the capacity of chief executive. We count 34 filings; the first trade dates from 30 June 2021 and the latest from 30 September 2026.

Every open-market trade on record is a sale: 4 sales worth €2.2M. The rest of the record consists of 4 share grants and 25 option exercises. In 2026 alone, the filings show no purchases and 4 sales.

The newest entry dates from 2 October 2026: an option exercise, in Monopar Therapeutics. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.